MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01345cam a2200289 4500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9283212762 |
| 035 ## - |
|---|
| -- |
(Sirsi) a69673 |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 268.5 2000IA |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
s2000 1 0 eng |
| 111 2# - MAIN ENTRY--MEETING NAME |
|---|
| Meeting name or jurisdiction name as entry element |
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : Some Antiviral and Antineoplastic Agents and other Pharmaceutical Agents |
| Date of meeting |
(1999: |
| Location of meeting |
Lyon, France) |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Some antiviral and antineoplastic agents and other pharmaceutical agents : |
| Remainder of title |
views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, 12-19 October 1999. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Lyon : |
| Name of publisher, distributor, etc. |
International Agency for Research on Cancer, |
| Date of publication, distribution, etc. |
2000. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
487 p. + cumulated index. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
IARC monographs on the evaluation of carcinogenic risks to humans ; |
| Volume/sequential designation |
v. 76 |
| 550 ## - ISSUING BODY NOTE |
|---|
| Issuing body note |
WHODOC |
| 561 ## - OWNERSHIP AND CUSTODIAL HISTORY |
|---|
| History |
WHO monograph |
| 596 ## - |
|---|
| -- |
4 |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Carcinogens. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antiviral agents |
| General subdivision |
toxicity |
| -- |
adverse effects. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antineoplastic agents |
| General subdivision |
toxicity |
| -- |
adverse effects. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical preparations |
| General subdivision |
toxicity |
| -- |
adverse effects. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug therapy |
| General subdivision |
adverse effects. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Neoplasms |
| General subdivision |
chemically induced. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Pharmaceuticals and Biologicals. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
International Agency for Research on Cancer. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
NLM Classification Scheme |
| Koha item type |
Books |
